07/07/2020
Ottawa, Ontario — Tuesday July 7, 2020

Dr. Tommy Alain’s study “Development of an Oral Reovirus- Based Vaccination Platform for COVID-19.”, received the Natural Sciences and Engineering Research Council of Canada Alliance Grant for $50,000.00
A grant share with Drs. Shawn Beug (CHEO RI) and Guy Lemay (Université de Montréal), they will use a unique and safe virus from their partner Virocure to develop a vaccine platform that can be given orally.